Cargando…
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482648/ https://www.ncbi.nlm.nih.gov/pubmed/34588001 http://dx.doi.org/10.1186/s40478-021-01258-8 |
| _version_ | 1784576952751882240 |
|---|---|
| author | Finkelstein, David I. Billings, Jessica L. Adlard, Paul A. Ayton, Scott Sedjahtera, Amelia Masters, Colin L. Wilkins, Simon Shackleford, David M. Charman, Susan A. Bal, Wojciech Zawisza, Izabela A. Kurowska, Ewa Gundlach, Andrew L. Ma, Sheri Bush, Ashley I. Hare, Dominic J. Doble, Philip A. Crawford, Simon Gautier, Elisabeth C. L. Parsons, Jack Huggins, Penny Barnham, Kevin J. Cherny, Robert A. |
| author_facet | Finkelstein, David I. Billings, Jessica L. Adlard, Paul A. Ayton, Scott Sedjahtera, Amelia Masters, Colin L. Wilkins, Simon Shackleford, David M. Charman, Susan A. Bal, Wojciech Zawisza, Izabela A. Kurowska, Ewa Gundlach, Andrew L. Ma, Sheri Bush, Ashley I. Hare, Dominic J. Doble, Philip A. Crawford, Simon Gautier, Elisabeth C. L. Parsons, Jack Huggins, Penny Barnham, Kevin J. Cherny, Robert A. |
| author_sort | Finkelstein, David I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8482648 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84826482021-10-04 Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease Finkelstein, David I. Billings, Jessica L. Adlard, Paul A. Ayton, Scott Sedjahtera, Amelia Masters, Colin L. Wilkins, Simon Shackleford, David M. Charman, Susan A. Bal, Wojciech Zawisza, Izabela A. Kurowska, Ewa Gundlach, Andrew L. Ma, Sheri Bush, Ashley I. Hare, Dominic J. Doble, Philip A. Crawford, Simon Gautier, Elisabeth C. L. Parsons, Jack Huggins, Penny Barnham, Kevin J. Cherny, Robert A. Acta Neuropathol Commun Correction BioMed Central 2021-09-29 /pmc/articles/PMC8482648/ /pubmed/34588001 http://dx.doi.org/10.1186/s40478-021-01258-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Finkelstein, David I. Billings, Jessica L. Adlard, Paul A. Ayton, Scott Sedjahtera, Amelia Masters, Colin L. Wilkins, Simon Shackleford, David M. Charman, Susan A. Bal, Wojciech Zawisza, Izabela A. Kurowska, Ewa Gundlach, Andrew L. Ma, Sheri Bush, Ashley I. Hare, Dominic J. Doble, Philip A. Crawford, Simon Gautier, Elisabeth C. L. Parsons, Jack Huggins, Penny Barnham, Kevin J. Cherny, Robert A. Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease |
| title | Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease |
| title_full | Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease |
| title_fullStr | Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease |
| title_full_unstemmed | Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease |
| title_short | Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease |
| title_sort | correction to: the novel compound pbt434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of parkinson’s disease |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482648/ https://www.ncbi.nlm.nih.gov/pubmed/34588001 http://dx.doi.org/10.1186/s40478-021-01258-8 |
| work_keys_str_mv | AT finkelsteindavidi correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT billingsjessical correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT adlardpaula correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT aytonscott correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT sedjahteraamelia correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT masterscolinl correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT wilkinssimon correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT shackleforddavidm correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT charmansusana correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT balwojciech correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT zawiszaizabelaa correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT kurowskaewa correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT gundlachandrewl correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT masheri correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT bushashleyi correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT haredominicj correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT doblephilipa correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT crawfordsimon correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT gautierelisabethcl correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT parsonsjack correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT hugginspenny correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT barnhamkevinj correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease AT chernyroberta correctiontothenovelcompoundpbt434preventsironmediatedneurodegenerationandalphasynucleintoxicityinmultiplemodelsofparkinsonsdisease |